D. E. Shaw & Co., Inc. Amgen Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $9.06 Million - $11 Million	-34,500 Reduced 40.35%	51,000 $15.9 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $6.18 Million - $7.46 Million	23,000 Added 36.8%	85,500 $24.3 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $5.11 Million - $5.77 Million	20,000 Added 47.06%	62,500 $18 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $4.37 Million - $5.43 Million	20,000 Added 88.89%	42,500 $11.4 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $5.89 Million - $6.97 Million	-27,500 Reduced 55.0%	22,500 $5 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $11.3 Million - $13.8 Million	50,000 New	50,000 $12.1 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $20.2 Million - $22.8 Million	-90,000 Reduced 65.45%	47,500 $10.7 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $13.3 Million - $14.8 Million	57,500 Added 71.88%	137,500 $33.5 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.14 Million - $1.26 Million	5,200 Added 6.95%	80,000 $19.3 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $4.79 Million - $5.49 Million	-24,100 Reduced 24.37%	74,800 $16.8 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $11.2 Million - $13.1 Million	52,600 Added 113.61%	98,900 $21 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $3.2 Million - $3.55 Million	-13,700 Reduced 22.83%	46,300 $11.3 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $1.44 Million - $1.68 Million	6,500 Added 12.15%	60,000 $14.9 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $9.41 Million - $11.2 Million	43,500 Added 435.0%	53,500 $12.3 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $4.69 Million - $5.22 Million	-20,000 Reduced 66.67%	10,000 $2.54 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $4.45 Million - $5.46 Million	-22,500 Reduced 42.86%	30,000 $7.08 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1.91 Million - $2.54 Million	10,500 Added 25.0%	52,500 $10.6 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $5.54 Million - $7.13 Million	-29,300 Reduced 41.09%	42,000 $10.1 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $4.88 Million - $5.84 Million	-28,000 Reduced 28.2%	71,300 $13.8 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $15.9 Million - $18.6 Million	95,200 Added 2321.95%	99,300 $18.3 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $2.33 Million - $2.63 Million	-12,600 Reduced 75.45%	4,100 $850,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $547,965 - $615,483	3,300 Added 24.63%	16,700 $3.08 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $34.8 Million - $40.6 Million	-205,300 Reduced 93.87%	13,400 $2.28 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $4.52 Million - $5.05 Million	26,800 Added 13.97%	218,700 $38 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $32.1 Million - $36.7 Million	191,900	191,900 $35.8 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.29M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account